Table 2.
Literature search of 40 identified “ULA-norm-Ad” hits in relation to their role in cancer.
Gene ID | Function/Expression | Type of Cancers | # |
---|---|---|---|
hsa-miR-137 | Tumor suppressor Anchorage-independent growth reduction |
Cervical [24,25,26,27,28], melanoma [29], acute lymphoblastic leukemia [30], pituitary adenoma [31], prolactinomas [32], pancreatic [33], endometrial [34], colon [35], glioblastoma [36], melanoma [37], bladder [38], liver [39], pancreatic [40], and other | 305 |
hsa-miR-129-5p | Tumor suppressor | Cervical [8,41,42,43], gastric [44,45], prostate [46], lung [47,48], colon [49], breast [50], pancreatic [51], liver [52], bladder [53], many other | 159 |
hsa-miR-491-5p | Tumor suppressor | Cervical [54,55,56], colon [57], osteosarcoma [58], gastric [59], many others | 49 |
hsa-miR-193b-3p | Tumor suppressor | Cervical [60], lung [61], ovarian [62], gastric [63], acute myeloid leukemia [64] | 43 |
hsa-miR-532-3p | Tumor suppressor Downregulated |
Cervical [65], colon [66], lung [67], lymphoma [68], prostate [69], tongue [70], breast [71] and other | 36 |
hsa-miR-646 | Tumor suppressor | Cervical [72], breasts [73], lung [74], gastric [75], many others | 31 |
hsa-miR-185-3p | Tumor suppressor Downregulated |
Cervical [76], prostate [77], colon [78], osteosarcoma [79], breast [80], nasopharyngeal [81], and other | 21 |
hsa-miR-1287 | Tumor suppressor Downregulated |
Cervical [82,83], breast [83,84,85,86,87,88], liver [87], colon [89], pancreatic [90], lung [88] and other | |
hsa-miR-22-5p | Tumor suppressor Downregulated |
Cervical [65,91,92,93], osteosarcoma, prostate, lung [93], and other | 16 |
hsa-miR-378c | Tumor suppressor Prognostic marker |
Cervical [94], gastric [95], Wilms tumor [96], head and neck [97] | 12 |
hsa-miR-193a-3p | Tumor suppressor | Lung [98,99,100], esophageal [101], liver [102], renal [103], osteosarcoma [104], colon [105], many others | 107 |
hsa-miR-608 | Tumor suppressor | Prostate [106], bladder [107], lung [108] | 80 |
hsa-miR-342-5p | Tumor suppressor | Breast [109,110,111], ovarian [112], colon [113], osteosarcoma [114], neuroblastoma [115,116] | 27 |
hsa-miR-4270 | Tumor suppressor | Lung [117,118], liver [119] | 10 |
hsa-miR-103a-2-5p | Tumor suppressor | Prostate [120], tongue [121], colon [122] | 5 |
hsa-miR-4749-5p | Tumor suppressor | Glioblastoma [123] | |
hsa-miR-1911-3p | Tumor suppressor | Lung [124] | |
hsa-miR-1250 | Tumor suppressor | Non-Hodgkin’s lymphoma [125] | |
hsa-miR-323a-5p | Tumor suppressor | Neuroblastoma [115,116] | |
hsa-miR-3680-3p | Tumor suppressor | Esophageal [126] | |
hsa-miR-1272 | Tumor suppressor | Prostate [127] | |
hsa-miR-5189 | Prognostic marker | Childhood B-cell acute lymphoblastic leukemia [128] | |
hsa-miR-4430 | Downregulated Prognostic marker |
Ovarium [129] | |
hsa-miR-224-3p | OncomiR | Cervical [130,131], osteosarcoma [132], lung [133] | 15 |
hsa-miR-766-5p | Upregulated, OncomiR | Cervical [134], promotes other cancers | 6 |
hsa-miR-3147 | Upregulated, OncomiR Prognostic marker |
Cervical [135], vulvar [136] | 2 |
hsa-miR-522-3p | OncomiR | Lung [137,138], colon [139] | 12 |
hsa-miR-425-3p | Upregulated Prognostic marker |
Liver [140], gastric [141], prostate [142], lung [143,144], colon [145] | 11 |
hsa-miR-1233-1-5p | Upregulated | Renal [146,147] esophageal [148] | |
hsa-miR-3916 | Upregulated, OncomiR | Melanoma [149], urothelial tract [150] | |
hsa-miR-4440 | Upregulated Prognostic marker |
Colon [151] | |
hsa-miR-4505 | Upregulated Prognostic marker |
Gastric [152] | |
No (cancer related) publications: hsa-miR-2277-5p, hsa-miR-4498, has-miR-5681a, has-miR-4436b-3p, hsa-miR-4706, hsa-miR-1263, hsa-miR-4265, hsa-miR-4746-3p |
# Number of cancer-related publications. For each miRNA we performed search in Pubmed using the word “cancer” and the number of listed publications is noted in the last column. miRNAs are sorted based on their relevance to cervical cancer following with the relevance to other cancers and the number of publications starting with tumor suppressive miRNAs and following with oncomiRs.